Balyasny Asset Management LLC Adamis Pharmaceuticals Corp Transaction History

Balyasny Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$0.92 - $1.18 $1.49 Million - $1.91 Million	-1,622,510 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$0.66 - $1.23 $1.07 Million - $2 Million	1,622,510 New	1,622,510 $1.79 Million
Q1 2018 May 15, 2018	SELL	$2.55 - $4.85 $563,550 - $1.07 Million	-221,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$3.5 - $5.65 $73,500 - $118,650	21,000 Added 10.5%	221,000 $972,000
Q3 2017 Nov 14, 2017	BUY	$4.5 - $5.65 $900,000 - $1.13 Million	200,000	200,000 $1.05 Million

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.